Novel protective mechanism of reducing renal cell damage in diabetes: Activation AMPK by AICAR increased NRF2/OGG1 proteins and reduced oxidative DNA damage

References

• Bonnefont-Rousselot D. Glucose and reactive oxygen species. Curr Opin Clin Nutr Metab Care 2002; 5:561-8; PMID:12172481; http://dx.doi.org/10.1097/00075197-200209000-00016
   PubMed Web of Science ®Google Scholar
• Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001; 414:813-20; PMID:11742414; http://dx.doi.org/10.1038/414813a
   PubMed Web of Science ®Google Scholar
• Lee HB, Yu MR, Yang Y, Jiang Z, Ha H. Reactive oxygen species-regulated signaling pathways in diabetic nephropathy. J Am Soc Nephrol 2003; 14:S241-5; PMID:12874439; http://dx.doi.org/10.1097/01.ASN.0000077410.66390.0F
   PubMed Web of Science ®Google Scholar
• Kasai H, Nishimura S. Formation of 8-hydroxyguanine by oxidative DNA damage, its repair and its mutagenic effects. In de Obe G. (ed.) Advances in mutagenesis Research. Springer-Verlag, Berlin, Germany, 1993; Vol. 4, pp.31-45.
   Google Scholar
• Nishikawa T, Sasahara T, Kiritoshi S. Evaluation of urinary 8-hydroxydeoxy-guanosine as a novel biomarker of macrovascular complications in type 2 diabetes. Diabetes Care 2003; 26:1507-12; PMID:12716813; http://dx.doi.org/10.2337/diacare.26.5.1507
   PubMed Web of Science ®Google Scholar
• Inokio Y, Suzuki S, Hirai M, Suzuki C, Suzuki M, Toyota T. Urinary excretion of 8-oxo-7, 8-dihydro-2′-deoxyguanosine as a predictor of the development of diabetic nephropathy. Diabetologia 2002; 45:877-82; PMID:12107732; http://dx.doi.org/10.1007/s00125-002-0831-8
   PubMed Web of Science ®Google Scholar
• Smart DJ, Chipman JK, Hodges NJ. Activity of OGG1 variants in the repair of prooxidant-induced 8-oxo-2′-deoxyguanosine. DNA Rep 2006; 5:1337-45; PMID:16861056; http://dx.doi.org/10.1016/j.dnarep.2006.06.001
   PubMed Web of Science ®Google Scholar
• Evans MD, Dizdaroglu M, Cooke MS. Oxidative DNA damage and disease: induction, repair and significance. Mutat Res 567:1-61; PMID:15341901; http://dx.doi.org/10.1016/j.mrrev.2003.11.001
   PubMed Web of Science ®Google Scholar
• Itoh K, Chiba T, Takahashi S, Ishii T, Igarashi K, Katoh Y, Oyake T, Hayashi N, Satoh K, Hatayama I, et al. An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochem Biophys Res Commun 1997; 236:313-22; PMID:9240432; http://dx.doi.org/10.1006/bbrc.1997.6943
   PubMed Web of Science ®Google Scholar
• Jain AK, Bloom DA, Jaiswal AK. Nuclear import and export signals in control of Nrf2. J Biol Chem 2005; 280:29158-68; PMID:15901726; http://dx.doi.org/10.1074/jbc.M502083200
   PubMed Web of Science ®Google Scholar
• Laderoute KR, Amin K, Calaoagan JM, Knapp M, Le T, Orduna J, Foretz M, Viollet B. 5′-AMP-Activated Protein Kinase (AMPK) Is Induced by Low-Oxygen and Glucose Deprivation Conditions Found in Solid-Tumor Microenvironments. Mol Cell Biol 2006; 26:5336-47; PMID:16809770; http://dx.doi.org/10.1128/MCB.00166-06
   PubMed Web of Science ®Google Scholar
• Guo D, Hildebrandt IJ, Prins RM, Soto H, Mazzotta MM, Dang J, Czernin J, Shyy JY, Watson AD, Phelps M, et al. The AMPK agonist AICAR inhibits the growth of EGFRvIII-expressing glioblastomas by inhibiting lipogenesis. Proc Natl Acad Sci U S A 2009; 106:12932-7; PMID:19625624; http://dx.doi.org/10.1073/pnas.0906606106
   PubMed Web of Science ®Google Scholar
• Winder WW, Thomson DM. Cellular energy sensing and signaling by AMP-activated protein kinase. Cell Biochem Biophys 2007; 47:332-47; PMID:17652779; http://dx.doi.org/10.1007/s12013-007-0008-7
   PubMed Web of Science ®Google Scholar
• Boon H, Bosselaar M, Praet SF, Blaak EE, Saris WH, Wagenmakers AJ, McGee SL, Tack CJ, Smits P, Hargreaves M, et al. Intravenous AICAR administration reduces hepatic glucose output and inhibits whole body lipolysis in type 2 diabetic patients. Diabetologia 2008; 51:1893-900; PMID:18709353; http://dx.doi.org/10.1007/s00125-008-1108-7
   PubMed Web of Science ®Google Scholar
• Terai K, Hiramoto Y, Masaki M, Sugiyama S, Kuroda T, Hori M, Kawase I, Hirota H. AMP-activated protein kinase protects cardiomyocytes against hypoxic injury through attenuation of endoplasmic reticulum stress. Mol Cell Biol 2005; 25:9554-75; PMID:16227605; http://dx.doi.org/10.1128/MCB.25.21.9554-9575.2005
   PubMed Web of Science ®Google Scholar
• Dong Y, Zhang M, Wang S, Liang B, Zhao Z, Liu C, Wu M, Choi HC, Lyons TJ, Zou MH. Activation of AMP-activated protein kinase inhibits oxidized LDL-triggered endoplasmic reticulum stress in vivo. Diabetes 2010; 59:1386-96; PMID:20299472; http://dx.doi.org/10.2337/db09-1637
   PubMed Web of Science ®Google Scholar
• Winder WW. Can patients with type 2 diabetes be treated with 5′-AMP-activated protein kinase activators? Diabetologia 2008; 51:1761-4; PMID:18696044; http://dx.doi.org/10.1007/s00125-008-1115-8
   PubMed Web of Science ®Google Scholar
• Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes 2005; 54:1615-25; PMID:15919781; http://dx.doi.org/10.2337/diabetes.54.6.1615
   PubMed Web of Science ®Google Scholar
• Halseth AE, Ensor NJ, White TA, Ross SA, Gulve EA. Acute and chronic treatment of ob/ob and db/db mice with AICAR decreases blood glucose concentrations. Biochem Biophys Res Commun 2002; 294:798-805; PMID:12061777; http://dx.doi.org/10.1016/S0006-291X(02)00557-0
   PubMed Web of Science ®Google Scholar
• Caton PW, Kieswich J, Yaqoob MM, Holness MJ, Sugden MC. Metformin opposes impaired AMPK and SIRT1 function and deleterious changes in core clock protein expression in white adipose tissue of genetically-obese db/db mice. Diabetes Obes Metab 2011; 13:1097-104; PMID:21733059; http://dx.doi.org/10.1111/j.1463-1326.2011.01466.x
   PubMed Web of Science ®Google Scholar
• Lee MN, Ha SH, Kim J, Koh A, Lee CS, Kim JH, Jeon H, Kim DH, Suh PG, Ryu SH. Glycolytic flux signals to mTOR through glyceraldehyde-3-phosphate dehydrogenase-mediated regulation of Rheb. Mol Cell Biol 2009; 29:3991-4001; PMID:19451232; http://dx.doi.org/10.1128/MCB.00165-09
   PubMed Web of Science ®Google Scholar
• Julien LA, Carriere A, Moreau J, Roux PP. mTORC1-activated S6K1 phosphorylates Rictor on threonine 1135 and regulates mTORC2 signaling. Mol Cell Biol 2010; 30:908-21; PMID:19995915; http://dx.doi.org/10.1128/MCB.00601-09
   PubMed Web of Science ®Google Scholar
• Samikkannu T, Thomas JJ, Bhat GJ, Wittman V, Thekkumkara TJ. Acute effect of high glucose on long-term cell growth: a role for transient glucose increase in proximal tubule cell injury. Am J Physiol Renal Physiol 2006; 291:F162-75; PMID:16467130; http://dx.doi.org/10.1152/ajprenal.00189.2005
   PubMed Web of Science ®Google Scholar
• Cui W, Li B, Bai Y, Miao X, Chen Q, Sun W, Tan Y, Luo P, Zhang C, Zheng S, et al. Potential role for Nrf2 activation in the therapeutic effect of MG132 on diabetic nephropathy in OVE26 diabetic mice. Am J Physiol Endocrinol Metab 2013; 304:E87-99; PMID:23132297; http://dx.doi.org/10.1152/ajpendo.00430.2012
   PubMed Web of Science ®Google Scholar
• Simone S, Gorin Y, Velagapudi C, Habib SL. Mechanism of oxidative DNA damage in diabetes: tuberin inactivation and downregulation of DNA repair enzyme 8-oxo-7,8-dihydro-2′-deoxyguanosine-DNA glycosylase. Diabetes 2008; 57:2626-36; PMID:18599524; http://dx.doi.org/10.2337/db07-1579
   PubMed Web of Science ®Google Scholar
• Roseborough G, Gao D, Chen L, Trush MA, Zhou S, Williams GM, Wei C. The mitochondrial K-ATP channel opener, diazoxide, prevents ischemia-reperfusion injury in the rabbit spinal cord. Am J Pathol 2006; 168:1443-51; PMID:16651612; http://dx.doi.org/10.2353/ajpath.2006.050569
   PubMed Web of Science ®Google Scholar
• Sakuraba H, Mizukami H, Yagihashi N, Wada R, Hanyu C, Yagihashi S. Reduced beta-cell mass and expression of oxidative stress-related DNA damage in the islet of Japanese type II diabetic patients. Diabetologia 2002; 45:85-96; PMID:11845227; http://dx.doi.org/10.1007/s125-002-8248-z
   PubMed Web of Science ®Google Scholar
• Habib SL, Riley DJ, Bhandari B, et al. Tuberin Regulates the DNA Repair Enzyme OGG1. Am J Physiol Renal Physiol 2008; 294:F281-90; PMID:17989114; http://dx.doi.org/10.1152/ajprenal.00370.2007
   PubMed Web of Science ®Google Scholar
• Dhenaut A, Boiteux S, Radicella JP. Characterization of the hOGG1 promoter and its expression during the cell cycle. Mutat Res 2000; 461:109-18; PMID:11018584; http://dx.doi.org/10.1016/S0921-8777(00)00042-2
   PubMed Web of Science ®Google Scholar
• Habib SL, Kasinath BS, Arya RR, Vexler S, Velagapudi C. Novel mechanism of reducing tumourigenesis: upregulation of the DNA repair enzyme OGG1 by rapamycin-mediated AMPK activation and mTOR inhibition. Eur J Cancer 2010; 46:2806-20; PMID:20656472; http://dx.doi.org/10.1016/j.ejca.2010.06.117
   PubMed Web of Science ®Google Scholar
• Habib SL, Bhandari BK, Sadek N, Abboud-Werner SL, Abboud HE. Novel Mechanism of Regulation of the DNA repair enzyme OGG1 in Tuberin-deficient Cells. Carcinogenesis 2010; 31:2022-30; PMID:20837600; http://dx.doi.org/10.1093/carcin/bgq189
   PubMed Web of Science ®Google Scholar
• Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72:248-54; PMID:942051; http://dx.doi.org/10.1016/0003-2697(76)90527-3
   PubMed Web of Science ®Google Scholar
• Habib SL, Simone S, Barnes JJ, Abboud HE. Tuberin Haploinsufficiency is Associated with the Loss of OGG1 in Rat Kidney Tumors. Mol Cancer 2008; 7:10-14; PMID:18218111; http://dx.doi.org/10.1186/1476-4598-7-10
   PubMed Web of Science ®Google Scholar
• Habib SL, Yadav M, Tizani S, Bhandari B, Valente AJ. Tuberin inhibits production of the matrix protein fibronectin in diabetes. J Am Soc Nephrol 2012; 2310:1652-62; http://dx.doi.org/10.1681/ASN.2012030285
   Web of Science ®Google Scholar
• Habib SL, Phan MN, Patel SK, Li D, Monks TJ, Lau SS. Reduced constitutive 8-oxoguanine-DNA glycosylase expression and impaired induction following oxidative DNA damage in the tuberin deficient Eker rat. Carcinogenesis 2003; 24:573-82; PMID:12663520; http://dx.doi.org/10.1093/carcin/24.3.573
   PubMed Web of Science ®Google Scholar